KALV

Kalvista Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 3/10
  • Momentum↑ 7/10
Kalvista Pharmaceuticals sales and earnings growth
KALV Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ 0.00%
Kalvista Pharmaceuticals gross and profit margin trends
KALV Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ 0.00%
Kalvista Pharmaceuticals net debt vs free cash flow
KALV Risk
Great
  • Debt / Equity↑ 8.7
  • Debt / FCF↓ 0.0
  • Interest coverage↓ 0.0

Kalvista Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗